Catabolism of pemphigus foliaceus autoantibodies by high-dose IVIg therapy
Yumi Aoyama(Tokyo Women's Medical University Adachi Medical Center), Yasuo Kitajima(Hiroshima University), Keiji Iwatsuki(Okayama University), Miki Nagai(Okayama University Hospital), Chie Moriya(Okayama University Hospital), Koji Kamiya(Jichi Medical University), David Rubenstein(Hospital for Sick Children)
Cited by 9
Related Papers
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
Defining early mycosis fungoides
|Journal of the American Academy of Dermatology|2005|543
Evaluation of the Skin Surface Hydration in Vivo by Electrical Measurement
|Journal of Investigative Dermatology|1980|345
Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City
|Archives of Pediatrics and Adolescent Medicine|2020|255